Since this edition of NICE Bites was published, NICE has updated these guidelines. CG97 includes a recommendation not to offer phosphodiesterase-5-inhibitors for the purpose of treating LUTS in men, except as part of a randomised controlled trial. CG99 includes new information from manufacturers to inform table 4. Please go to NICE for details and to check for any further updates to these guidelines.
NICE Bites is a monthly bulletin which summarises key prescribing points from NICE guidance. NICE Bites No 18, June 2010 includes two topics:
Lower urinary tract symptoms (LUTS) in men (CG97). Sections covered include: assessment, conservative management, pharmacological treatment (alpha blockers, anticholinergics, 5-alpha reductase inhibitors, diuretics, desmopressin), monitoring, cautions and counselling.
Chronic constipation in children (CG99). Sections covered include: diagnosis, lifestyle interventions, pharmacological treatment (laxatives), cautions and counselling.